Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
Market Analysis and Insights: Global Post herpetic Neuralgia Treatment Market
Due to the COVID-19 pandemic, the global Post herpetic Neuralgia Treatment market size is estimated to be worth US$ 1586 million in 2021 and is forecast to a readjusted size of US$ 1586 million by 2028 with a CAGR of 4.0% during the review period. Fully considering the economic change by this health crisis, by Type accounting for % of the Post herpetic Neuralgia Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Type segment is altered to an % CAGR throughout this forecast period.
Global Post herpetic Neuralgia Treatment key players include Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, etc. Global top five manufacturers hold a share about 80%.
North America is the largest market, with a share over 50%, followed by Europe and China, both have a share about 30 percent.
In terms of product, Anticonvulsants is the largest segment, with a share over 80%. And in terms of distribution channel, the largest distribution channel is Hospital Pharmacies, followed by Retail Pharmacies.
Global Post herpetic Neuralgia Treatment Scope and Market Size
The global Post herpetic Neuralgia Treatment market is segmented by company, region (country), by Type and by Distribution Channel. Players, stakeholders, and other participants in the global Post herpetic Neuralgia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Distribution Channel for the period 2017-2028.
Segment by Type
Anticonvulsants
Skin Patch
Other
Segment by Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Pfizer
Arbor Pharma
Assertio Therapeutics
Endo Pharma
Teikoku Pharma
Teva
Mylan
Hengrui Medicine
Market Analysis and Insights: Global Post herpetic Neuralgia Treatment Market
Due to the COVID-19 pandemic, the global Post herpetic Neuralgia Treatment market size is estimated to be worth US$ 1586 million in 2021 and is forecast to a readjusted size of US$ 1586 million by 2028 with a CAGR of 4.0% during the review period. Fully considering the economic change by this health crisis, by Type accounting for % of the Post herpetic Neuralgia Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Type segment is altered to an % CAGR throughout this forecast period.
Global Post herpetic Neuralgia Treatment key players include Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, etc. Global top five manufacturers hold a share about 80%.
North America is the largest market, with a share over 50%, followed by Europe and China, both have a share about 30 percent.
In terms of product, Anticonvulsants is the largest segment, with a share over 80%. And in terms of distribution channel, the largest distribution channel is Hospital Pharmacies, followed by Retail Pharmacies.
Global Post herpetic Neuralgia Treatment Scope and Market Size
The global Post herpetic Neuralgia Treatment market is segmented by company, region (country), by Type and by Distribution Channel. Players, stakeholders, and other participants in the global Post herpetic Neuralgia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Distribution Channel for the period 2017-2028.
Segment by Type
Anticonvulsants
Skin Patch
Other
Segment by Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Pfizer
Arbor Pharma
Assertio Therapeutics
Endo Pharma
Teikoku Pharma
Teva
Mylan
Hengrui Medicine
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
